Merge Healthcare Incorporated:企業のM&A・事業提携・投資動向

◆英語タイトル:Merge Healthcare Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2096
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:85
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Merge Healthcare Incorporated – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Merge Healthcare Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Merge Healthcare Incorporated since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Merge Healthcare Incorporated’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Merge Healthcare Incorporated. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Merge Healthcare Incorporated’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Merge Healthcare Incorporated and its subsidiaries since 2007.
- Information about key financial and legal advisors for Merge Healthcare Incorporated’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Merge Healthcare Incorporated’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Overview 7
Mergers and Acquisitions – Deal reports 8
PARTNERSHIP 29
Partnership – Overview 29
Partnership – Deal reports 30
CAPITAL RAISING 59
Capital Raising – Deal reports 59
Divestments – Deal reports 69
PRIVATE EQUITY & OWNERSHIP 71
Private Equity and Ownership – Overview 71
Private Equity and Ownership – Deal reports 72
APPENDIX 75
Contact Us 75
About MarketLine Financial Deals Database 75
Deal Definition and Methodology 77
About MarketLine 84

List of Tables
Table 1: Merge Healthcare Incorporated M&A volume and value trend (2014-YTD2018)
Table 2: Merge Healthcare Incorporated M&A activity by geography (2014-YTD2018)
Table 3: Merge Healthcare Incorporated partnership volume and value trend (2014-YTD2018)
Table 4: Merge Healthcare Incorporated partnership trend by key deal type (2014-YTD2018)
Table 5: Merge Healthcare Incorporated private equity and ownership volume and value trend (2014-YTD2018)
Table 6: Merge Healthcare Incorporated private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Merge Healthcare Incorporated M&A volume and value trend (2014-YTD2018)
Figure 2: Merge Healthcare Incorporated M&A activity by geography (2014-YTD2018)
Figure 3: Merge Healthcare Incorporated partnership volume and value trend (2014-YTD2018)
Figure 4: Merge Healthcare Incorporated partnership trend by key deal type (2014-YTD2018)
Figure 5: Merge Healthcare Incorporated private equity and ownership volume and value trend (2014-YTD2018)
Figure 6: Merge Healthcare Incorporated private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Merge Healthcare Incorporated:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • N4 Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary N4 Pharma Ltd (n4 Pharma), a subsidiary of N4 Pharma Plc, is a drug reformulation company. The company develops and out licensing of new versions of existing high value drugs with an unmet commercial or medical need. Its proprietary platform technology, Cocrys and Nuvac, focus on improving t …
  • Integer Holdings Corp (ITGR):医療機器:M&Aディール及び事業提携情報
    Summary Integer Holdings Corp (Integrated Holdings), formerly Greatbatch Inc is a medical device outsource manufacturer that designs and develops medical devices and power solutions for the medical and non-medical markets. The company offers products such as arthroscopic devices and components, lapa …
  • Sirtex Medical Ltd (SRX):医療機器:M&Aディール及び事業提携情報
    Summary Sirtex Medical Ltd (Sirtex Medical) is a medical device company that develops and markets device for the treatment of liver cancer. The company’s sir-spheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors. Its product Y-90 resin micros …
  • Icon Genetics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Icon Genetics GmbH (Icon Genetics), a subsidiary of Denka Co Ltd, is a technology company that offers plant engineering technologies. The company develops, manufactures and markets biopharmaceutical product candidates, engineered organisms and technology platforms for plant biotechnology and …
  • APR Applied Pharma Research SA-医療機器分野:企業M&A・提携分析
    Summary APR Applied Pharma Research SA (APR) is a healthcare company which focuses on the development and licenses of healthcare products for rare therapeutic areas. The company offers consumer health products, prescription healthcare products and therapeutic products. APR’s product pipeline portfol …
  • Booz Allen Hamilton Holding Corporation (BAH):企業の財務・戦略的SWOT分析
    Booz Allen Hamilton Holding Corporation (BAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Aegion Corp (AEGN):企業の財務・戦略的SWOT分析
    Aegion Corp (AEGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Traverse Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Traverse Biosciences Inc (Traverse Biosciences) is an independent bioscience company that commercializes drug candidates for the treatment of inflammatory diseases and age-related conditions affecting humans and companion animals. The company’s lead candidate TRB-N0224 is developed for canin …
  • Nohla Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nohla Therapeutics Inc (Nohla Therapeutics) focuses on the development of universal, off-the-shelf cell therapies for the treatment of hematologic malignancies and other critical diseases. The company develops clinical, preclinical and discovery programs based on its proprietary notch ligand …
  • Talon Metals Corp.
    Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report Summary Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Findel plc:企業の戦略・SWOT・財務分析
    Findel plc - Strategy, SWOT and Corporate Finance Report Summary Findel plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Confluent Medical Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Confluent Medical Technologies Inc (CMT), formerly Nitinol Devices and Components Inc is a medical device company that manufactures and markets nitinol devices and balloon catheters. The company’s products include wire, strip, sheet, tubing, and bar. Its development services include finite e …
  • BioRestorative Therapies Inc (BRTX):医療機器:M&Aディール及び事業提携情報
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • Kering SA:企業のM&A・事業提携・投資動向
    Kering SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kering SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Ginkgo BioWorks Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ginkgo BioWorks Inc (Ginkgo BioWorks) is a biotechnology company which offers automated organism engineering, enzyme discovery and cultured fragrances. The company build's foundries to scale the process of organism engineering using software and hardware automation tools. It produces ingredi …
  • Staffline Group plc:企業のM&A・事業提携・投資動向
    Staffline Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Staffline Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Fuji Chemical Industry Co Ltd:企業の戦略・SWOT・財務情報
    Fuji Chemical Industry Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fuji Chemical Industry Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ak Bars Bank:企業の戦略・SWOT・財務分析
    Ak Bars Bank - Strategy, SWOT and Corporate Finance Report Summary Ak Bars Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • JSFC Sistema (AFKS):石油・ガス:M&Aディール及び事業提携情報
    Summary JSFC Sistema (Sistema) is a diversified holding company which offers a wide range of consumer services in Russia and the Commonwealth of Independent States (CIS).The company undertakes businesses in various sectors, including telecommunications, high technology, real estate development, reta …
  • Tesla Energy Operations Inc:企業の戦略的SWOT分析
    Tesla Energy Operations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆